Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-01 Sale | 2024-11-04 4:34 pm | NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology | 598 | $15.94 | $9,531 | 161,236 (Direct) | View |
| 2024-03-01 Sale | 2024-03-05 4:08 pm | NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology | 2,519 | $16.02 | $40,358 | 160,098 (Direct) | View |
| 2024-02-28 Sale | 2024-02-29 4:38 pm | NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology | 2,078 | $16.14 | $33,545 | 318,965 (Direct) | View |
| 2023-03-03 Sale | 2023-03-07 4:52 pm | NovoCure Ltd | NVCR | Leonard Frank X President, CNS Cancers US | 13,609 | $75.55 | $1,028,165 | 54,284 (Direct) | View |
| 2023-03-02 Sale | 2023-03-06 4:37 pm | NovoCure Ltd | NVCR | Leonard Frank X President, CNS Cancers US | 2,903 | $76.95 | $223,393 | 67,893 (Direct) | View |
| 2023-03-02 Sale | 2023-03-03 4:13 pm | NovoCure Ltd | NVCR | Leonard Frank X President, CNS Cancers US | 4,107 | $75.38 | $309,578 | 58,988 (Direct) | View |
| 2023-03-01 Sale | 2023-03-02 5:01 pm | NovoCure Ltd | NVCR | Leonard Frank X President, CNS Cancers US | 1,684 | $76.36 | $128,594 | 94,066 (Direct) | View |
| 2023-01-05 Sale | 2023-01-09 6:21 pm | NovoCure Ltd | NVCR | Leonard Frank X President, CNS Cancers US | 39,507 | $112.25 | $4,434,654 | 74,299 (Direct) | View |
| 2022-10-13 Sale | 2022-10-17 4:35 pm | NovoCure Ltd | NVCR | Leonard Frank X President, CNS Cancers US | 6,754 | $76.01 | $513,372 | 43,626 (Direct) | View |
| 2022-10-06 Sale | 2022-10-07 4:16 pm | NovoCure Ltd | NVCR | Leonard Frank X President, CNS Cancers US | 6,754 | $84.37 | $569,835 | 50,380 (Direct) | View |
| 2022-09-29 Sale | 2022-09-30 4:20 pm | NovoCure Ltd | NVCR | Leonard Frank X President, CNS Cancers US | 6,754 | $77.35 | $522,422 | 57,134 (Direct) | View |
| 2022-09-22 Sale | 2022-09-26 4:19 pm | NovoCure Ltd | NVCR | Leonard Frank X President, CNS Cancers US | 6,754 | $77 | $520,058 | 63,888 (Direct) | View |
| 2022-09-15 Sale | 2022-09-19 4:10 pm | NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer | 12,271 | $88.52 | $1,086,222 | 76,159 (Direct) | View |
| 2022-09-08 Sale(A) | 2022-09-13 4:15 pm | NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer | 6,754 | $81.48 | $550,316 | 77,396 (Direct) | View |
| 2022-09-09 Sale | 2022-09-12 4:32 pm | NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer | 1,863 | $88 | $163,944 | 84,150 (Direct) | View |
| 2022-09-06 Sale | 2022-09-07 4:27 pm | NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer | 1,384 | $78.57 | $108,741 | 86,013 (Direct) | View |
| 2022-09-01 Sale | 2022-09-06 4:19 pm | NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer | 14,796 | $77.5 | $1,146,634 | 87,397 (Direct) | View |
| 2022-08-02 Sale | 2022-08-03 4:44 pm | NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer | 414 | $69.66 | $28,839 | 102,193 (Direct) | View |
| 2022-03-08 Sale | 2022-03-09 4:55 pm | NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer | 744 | $70.1 | $52,154 | 102,295 (Direct) | View |
| 2022-03-03 Sale | 2022-03-07 6:14 pm | NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer | 1,485 | $72.97 | $108,359 | 138,394 (Direct) | View |
| 2021-09-02 Sale | 2021-09-07 4:39 pm | NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer | 540 | $138.23 | $74,645 | 87,153 (Direct) | View |
| 2021-08-02 Sale | 2021-08-04 5:20 pm | NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer | 1,041 | $149.39 | $155,520 | 89,158 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-28 Option Award | 2024-08-06 4:17 pm | N/A N/A | NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology | 1,736 | $12.24 | 161,834 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 4:38 pm | 2025-02-27 2034-02-26 | NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology | 258,597 | $16.3 | 318,965 (Direct) | View |
Ownership | 2024-01-12 4:57 pm | N/A N/A | NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology | 0 | $0 | 227,173 (Direct) | View |
| 2023-03-03 Option Award | 2023-03-06 4:37 pm | N/A N/A | NovoCure Ltd | NVCR | Leonard Frank X President, CNS Cancers US | 11,808 | $0 | 67,893 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-02 5:01 pm | 2024-02-28 2033-02-27 | NovoCure Ltd | NVCR | Leonard Frank X President, CNS Cancers US | 30,971 | $76.97 | 94,066 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-02 5:01 pm | N/A N/A | NovoCure Ltd | NVCR | Leonard Frank X President, CNS Cancers US | 18,621 | $0 | 94,066 (Direct) | View |
| 2023-01-05 Exercise | 2023-01-09 6:21 pm | N/A 2025-02-23 | NovoCure Ltd | NVCR | Leonard Frank X President, CNS Cancers US | 35,209 | $0 | 74,299 (Direct) | View |
| 2023-01-05 Exercise | 2023-01-09 6:21 pm | N/A N/A | NovoCure Ltd | NVCR | Leonard Frank X President, CNS Cancers US | 7,826 | $14.37 | 74,299 (Direct) | View |
| 2023-01-05 Exercise | 2023-01-09 6:21 pm | N/A N/A | NovoCure Ltd | NVCR | Leonard Frank X President, CNS Cancers US | 5,517 | $7.15 | 74,299 (Direct) | View |
| 2023-01-05 Exercise | 2023-01-09 6:21 pm | N/A N/A | NovoCure Ltd | NVCR | Leonard Frank X President, CNS Cancers US | 7,500 | $11.46 | 74,299 (Direct) | View |
| 2023-01-05 Exercise | 2023-01-09 6:21 pm | N/A N/A | NovoCure Ltd | NVCR | Leonard Frank X President, CNS Cancers US | 7,183 | $21.15 | 74,299 (Direct) | View |
| 2022-11-01 Option Award | 2022-11-03 4:42 pm | 2023-11-01 2032-10-31 | NovoCure Ltd | NVCR | Leonard Frank X President, CNS Cancers US | 11,609 | $73.2 | 62,065 (Direct) | View |
| 2022-11-01 Option Award | 2022-11-03 4:42 pm | N/A N/A | NovoCure Ltd | NVCR | Leonard Frank X President, CNS Cancers US | 6,830 | $0 | 62,065 (Direct) | View |
| 2022-09-15 Exercise | 2022-09-19 4:10 pm | N/A 2027-02-21 | NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer | 5,517 | $0 | 76,159 (Direct) | View |
| 2022-09-15 Exercise | 2022-09-19 4:10 pm | N/A N/A | NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer | 5,517 | $7.15 | 76,159 (Direct) | View |
| 2022-07-05 Option Award | 2022-07-07 5:46 pm | N/A N/A | NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer | 312 | $59.08 | 102,607 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-07 6:14 pm | 2023-03-01 2032-02-29 | NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer | 35,355 | $80.59 | 138,394 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-07 6:14 pm | N/A N/A | NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer | 17,371 | $0 | 138,394 (Direct) | View |
| 2021-07-06 Option Award | 2021-07-08 5:36 pm | N/A N/A | NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer | 154 | $137.12 | 90,199 (Direct) | View |
| 2021-03-02 Option Award | 2021-03-04 5:55 pm | N/A 2031-03-01 | NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer | 24,712 | $0 | 107,380 (Direct) | View |
| 2021-02-27 Exercise | 2021-03-02 4:12 pm | 2021-02-27 N/A | NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer | 1,465 | $0 | 83,098 (Direct) | View |
| 2021-02-27 Exercise | 2021-03-02 4:12 pm | N/A N/A | NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer | 1,465 | $149.1 | 83,098 (Direct) | View |
Ownership | 2020-09-10 8:20 pm | N/A N/A | NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer | 0 | $0 | 223,330 (Direct) | View |
| 2020-09-01 Option Award | 2020-09-04 4:38 pm | N/A 2030-08-31 | NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer | 17,240 | $0 | 92,969 (Direct) | View |